NexImmune (NEXI) Earnings Date, Estimates & Call Transcripts → Does this make you sick? (From Allegiance Gold) (Ad) Free NEXI Stock Alerts $3.21 -0.13 (-3.89%) (As of 05/20/2024 ET) Add Compare Share Share EarningsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryLatest Earnings DateApr. 16EstimatedActual EPS (Apr. 16) -$4.99 Missed By -$4.99 Get NexImmune Earnings AlertsEnter your email address below to receive the latest news and earnings results for NEXI and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueNEXI Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.NEXI Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Allegiance GoldDoes this make you sick?The US Dollar Is "Finished" A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments.Get your Free Wealth Protection Kit NEXI Earnings Date and InformationNexImmune last issued its quarterly earnings results on April 16th, 2024. The reported ($4.99) earnings per share for the quarter. NexImmune has generated ($30.89) earnings per share over the last year (($30.89) diluted earnings per share). Read More NexImmune Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript4/16/2024Q4 2023-($4.99)($4.99)($4.99)--11/17/2023Q3 2023-($9.40)($9.40)($9.40)--8/10/2023Q2 2023($7.25)($7.25)-($0.29)--5/15/2023Q1 2023($11.25)($9.25)+$2.00($0.37)--3/28/2023Q4 2022($14.50)($16.25)($1.75)($0.65)--11/14/2022Q3 2022($16.50)($15.00)+$1.50($0.60)-- Get the Latest News and Ratings for NEXI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NexImmune and its competitors with MarketBeat's FREE daily newsletter. 8/15/2022Q2 2022($16.50)($17.25)($0.75)($0.69)--5/12/2022Q1 2022($17.75)($16.50)+$1.25($0.66)-- 3/9/2022Q4 2021($21.00)($17.00)+$4.00($0.68)--11/12/2021Q3 2021($16.75)($16.25)+$0.50($0.65)--8/9/2021Q2 2021($13.50)($13.50)-($0.54)-- NexImmune Earnings - Frequently Asked Questions When did NexImmune announce their last quarterly earnings? NexImmune (NASDAQ:NEXI) last announced its quarterly earning data on Tuesday, April 16, 2024. Learn more on NEXI's earnings history. How much profit does NexImmune generate each year? NexImmune (NASDAQ:NEXI) has a recorded net income of -$32.34 million. NEXI has generated -$30.89 earnings per share over the last four quarters. More Earnings Resources from MarketBeat Related Companies: China Pharma Earnings Cingulate Earnings Bright Minds Biosciences Earnings Kintara Therapeutics Earnings TFF Pharmaceuticals Earnings TransCode Therapeutics Earnings Artelo Biosciences Earnings Synaptogenix Earnings GT Biopharma Earnings Clever Leaves Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Baidu Stock Earnings Prove Ray Dalio Right about China?JD’s Earnings Could Mean Chinese Stocks Making a ComebackHome Depot: Earnings Mixed, Wait to Buy the DipTraders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-Turn This page (NASDAQ:NEXI) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsDoes this make you sick?Allegiance Gold[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 Media4 Cryptos BETTER than BitcoinTrue Market InsidersBill Clinton Backing Biden Replacement???The Freeport SocietyThe #1 Crypto for AIWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NexImmune, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.